Drug Chatter -- Tracking biopharma stock chatter

Profile for Lifevantage Corporation (LXRX)

« Back to company index

LXRX Chatter Timeline

Stock Ticker for LXRX

Most Active Tweeters for LXRX

UserTweets
@AmericanBanking 7
@ConsumerFeed 5
@dispatchtribune 5
@CFinancialNews 5
@1MinuteStock 5

Recent Tweets for LXRX

TheMarketsDaily @TheMarketsDaily
Jeffrey L. Wade Buys 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/O14bSwrt34
November 16th 2017, 7:11pm
AmericanBanking @AmericanBanking
-$0.43 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/izu3pvlLuL
November 16th 2017, 5:11pm
TranscriptDaily @TranscriptDaily
-$0.43 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/8eXYUDVVcl
November 16th 2017, 5:11pm
intercooleronli @intercooleronli
-$0.43 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/BcoMUxDocB
November 16th 2017, 5:11pm
CFinancialNews @CFinancialNews
-$0.43 Earnings Per Share Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/vimW8WFkTU
November 16th 2017, 5:11pm
AmericanBanking @AmericanBanking
Analysts Give Average Rating of Hold to Lexicon Pharmaceuticals $LXRX https://t.co/akHlR6mxq7
November 16th 2017, 5:11pm
WatchlistN @WatchlistN
Zacks Investment Research Upgrades Lexicon Pharmaceuticals, Inc. $LXRX to Hold https://t.co/bGTl3U5QMI
November 16th 2017, 1:11pm
SpeedyCalls @SpeedyCalls
$LXRX 15 Puts BUYING Activity expiring on 19th Jan, Vol 448
November 16th 2017, 12:11pm
stocknewstimes @stocknewstimes
Public Equities L.P. Invus Buys 145,680 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/7ox0rPRv7w
November 16th 2017, 7:11am
SleekMoneycom @SleekMoneycom
Public Equities L.P. Invus Buys 145,680 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/9xf9zET7On
November 16th 2017, 7:11am
storminvestor @storminvestor
Public Equities L.P. Invus Buys 575,946 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/0iFhTs5FT4
November 16th 2017, 4:11am
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals CEO Lonnel Coats Buys $99,100.00 in $LXRX https://t.co/WCsVzReSTM
November 15th 2017, 7:11pm
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals CEO Lonnel Coats Buys $99,100.00 in $LXRX https://t.co/4bGGG9wZtx
November 15th 2017, 7:11pm
WatchlistN @WatchlistN
Lexicon Pharmaceuticals, Inc. $LXRX EVP Jeffrey L. Wade Purchases 2,000 Shares of Stock https://t.co/qFWQM83nm9
November 15th 2017, 5:11pm
InsiderAlertsIA @InsiderAlertsIA
$LXRX: New Insider Filing on President and CEO LONNEL COATS: https://t.co/32iLSvU2cF
November 15th 2017, 5:11pm
emq_news @emq_news
Lexicon Pharmaceuticals, Inc. $LXRX Upgraded to “Hold” by Zacks Investment Research https://t.co/qceOJ23SkY
November 15th 2017, 4:11pm
alphabetastock @alphabetastock
Is the Stock Safe to Invest?: Lexicon Pharmaceuticals Inc $LXRX https://t.co/UIQbjmY41U
November 15th 2017, 2:11pm
QuantchaIdeas @QuantchaIdeas
Big Gainer Alert: Trading today’s 8.3% move in LEXICON PHARMACEUTICALS $LXRX https://t.co/8Rq83ZZ973 https://t.co/eShMuEpfkg
November 15th 2017, 12:11pm
Trader_gurl @Trader_gurl
$LXRX put $12 exp 15/12/17 buying detected https://t.co/QoM8mCyqmg
November 15th 2017, 11:11am
SpeedyCalls @SpeedyCalls
$LXRX 12 Puts BUYING Activity expiring on 15th Dec, Vol 200
November 15th 2017, 11:11am
tymorapro @tymorapro
$LXRX: At 1WkHIGH=10.10, hits:1, Rng:20%, ch:+7.0%, 4NewHi, 13:4Accel+, tf:0111111, medFlt:43M, HiPctSht[36%:12d], DyVol:478T:0.4x:0.4x
November 15th 2017, 11:11am
KeithKernBTB @KeithKernBTB
$LXRX nice bottom bounce potential and action today... 10 seems significant... https://t.co/7YVdaPo06O
November 15th 2017, 10:11am
ZolmaxNews @ZolmaxNews
Pictet Asset Management Ltd. Has $925,000 Position in Lexicon Pharmaceuticals, Inc. $LXRX https://t.co/ylB1kwqeyq
November 15th 2017, 10:11am
TranscriptDaily @TranscriptDaily
Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Drops By 13.8% https://t.co/nZJ0I7auEq
November 15th 2017, 3:11am
DrSManian @DrSManian
RT @ScatmanGL: @DrSManian one of your names $LXRX over $4 mln buy by Invus fund
November 15th 2017, 12:11am
AmericanBanking @AmericanBanking
Insider Buying: Lexicon Pharmaceuticals, Inc. $LXRX Director Purchases 145,680 Shares of Stock https://t.co/o4KxjKTYSB
November 14th 2017, 11:11pm
ConsumerFeed @ConsumerFeed
Insider Buying: Lexicon Pharmaceuticals, Inc. $LXRX Director Purchases 145,680 Shares of Stock https://t.co/3AHuCCA6Sy #acn
November 14th 2017, 11:11pm
TheMarketsDaily @TheMarketsDaily
Insider Buying: Lexicon Pharmaceuticals, Inc. $LXRX Director Purchases 145,680 Shares of Stock https://t.co/Li8D2Xsdea
November 14th 2017, 11:11pm
CFinancialNews @CFinancialNews
Insider Buying: Lexicon Pharmaceuticals, Inc. $LXRX Director Purchases 145,680 Shares of Stock https://t.co/1Z9DUS9RIG
November 14th 2017, 11:11pm
midetimes @midetimes
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/MsR5RtYq8L
November 14th 2017, 10:11pm
CFinancialNews @CFinancialNews
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/uw7sKQtBx1
November 14th 2017, 10:11pm
dailypoliticaln @dailypoliticaln
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/8Qbq6QtuVk
November 14th 2017, 9:11pm
dailymailtimes @dailymailtimes
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/07AJNvcewu
November 14th 2017, 9:11pm
WKRBNews @WKRBNews
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/EwWAJc26fU
November 14th 2017, 9:11pm
ConsumerFeed @ConsumerFeed
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/ph7YqNggkY #acn
November 14th 2017, 9:11pm
intercooleronli @intercooleronli
Jeffrey L. Wade Purchases 2,000 Shares of Lexicon Pharmaceuticals, Inc. $LXRX Stock https://t.co/j4UVFWXQZr
November 14th 2017, 9:11pm
ScatmanGL @ScatmanGL
@DrSManian one of your names $LXRX over $4 mln buy by Invus fund
November 14th 2017, 9:11pm
SPACE_TRADES @SPACE_TRADES
? $LXRX ~~~~~~~~~~~~~~~~~~~ ~(Company Report): https://t.co/G0L1Bfoq9K ~~~~~~~~~~~~~~~~~~~ ~(Daily Chart) & (Inside… https://t.co/IbLlRFhFGc
November 14th 2017, 8:11pm
StockTexts @StockTexts
$LXRX Lexicon Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/U41hJNyHKD
November 14th 2017, 7:11pm
InsiderAlertsIA @InsiderAlertsIA
$LXRX: New Insider Filing on EVP, Corp Adm Affairs and CFO JEFFREY L WADE: https://t.co/CjnzInto9d
November 14th 2017, 7:11pm
StockTexts @StockTexts
$LXRX Lexicon Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/d9Nlw8TSC5
November 14th 2017, 7:11pm
LargeVoidBot @LargeVoidBot
$LXRX Nov 14, CFO Buys 2000 Shrs; Net: 18.96k; Acq'd: 2000 9.48/s; Disp'd: 0 https://t.co/MXhMnUloCH
November 14th 2017, 7:11pm
SpeedyCalls @SpeedyCalls
$LXRX 12 Puts BUYING Activity expiring on 17th Nov, Vol 328
November 14th 2017, 9:11am
dispatchtribune @dispatchtribune
Lexicon Pharmaceuticals, Inc. $LXRX Rating Increased to Hold at Zacks Investment Research https://t.co/JfbB0zcchg
November 14th 2017, 7:11am
RatingsNetwork @RatingsNetwork
Lexicon Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/6fX3oKVlLZ $LXRX #LXRX
November 14th 2017, 3:11am
AmericanBanking @AmericanBanking
Lexicon Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/LG2ZuPovb0 $LXRX #LXRX
November 14th 2017, 3:11am
ConsumerFeed @ConsumerFeed
Lexicon Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/ZDuwwOobcc $LXRX #LXRX
November 14th 2017, 3:11am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $LXRX is $26.4 https://t.co/NPVCLnpzjt
November 13th 2017, 8:11am
ledgerzette @ledgerzette
Lexicon Pharmaceuticals, Inc. $LXRX Receives $25.33 Consensus PT from Brokerages https://t.co/OiALZ4omAs
November 13th 2017, 8:11am
dailypoliticaln @dailypoliticaln
Lexicon Pharmaceuticals, Inc. $LXRX Shares Up 0% https://t.co/5PK2AH1ao7
November 12th 2017, 10:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.